| Product Code: ETC7658475 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Parkinsons Disease Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Parkinsons Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Parkinsons Disease Treatment Market - Industry Life Cycle |
3.4 Israel Parkinsons Disease Treatment Market - Porter's Five Forces |
3.5 Israel Parkinsons Disease Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Parkinsons Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Parkinsons Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Israel |
4.2.2 Technological advancements in treatment options |
4.2.3 Growing healthcare infrastructure and investments in research and development |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease treatment |
4.3.2 Limited access to specialized healthcare services in some regions of Israel |
4.3.3 Stringent regulatory requirements for new treatment approvals |
5 Israel Parkinsons Disease Treatment Market Trends |
6 Israel Parkinsons Disease Treatment Market, By Types |
6.1 Israel Parkinsons Disease Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Carbidopa-Levodopa, 2021- 2031F |
6.1.4 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.1.5 Israel Parkinsons Disease Treatment Market Revenues & Volume, By MAO-B Inhibitors, 2021- 2031F |
6.1.6 Israel Parkinsons Disease Treatment Market Revenues & Volume, By COMT Inhibitors, 2021- 2031F |
6.1.7 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Parkinsons Disease Treatment Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.2.4 Israel Parkinsons Disease Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Israel Parkinsons Disease Treatment Market Import-Export Trade Statistics |
7.1 Israel Parkinsons Disease Treatment Market Export to Major Countries |
7.2 Israel Parkinsons Disease Treatment Market Imports from Major Countries |
8 Israel Parkinsons Disease Treatment Market Key Performance Indicators |
8.1 Number of clinical trials for Parkinson's disease treatments in Israel |
8.2 Adoption rate of new treatment modalities in the market |
8.3 Patient satisfaction and quality of life improvements post-treatment |
8.4 Rate of healthcare professionals trained in Parkinson's disease management |
8.5 Investment in Parkinson's disease research and development in Israel |
9 Israel Parkinsons Disease Treatment Market - Opportunity Assessment |
9.1 Israel Parkinsons Disease Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Parkinsons Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Parkinsons Disease Treatment Market - Competitive Landscape |
10.1 Israel Parkinsons Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Parkinsons Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here